Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients

BACKGROUND: High titer donor-specific antibodies (DSA) and positive crossmatch in cardiac transplant recipients is associated with increased mortality from antibody-mediated rejection (AMR). Although treatment to reduce antihuman leukocyte antigen antibodies using plasmapheresis, intravenous immunog...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Morrow, William Robert, Frazier, Elizabeth A., Mahle, William T., Harville, Terry O., Pye, Sherry E., Knecht, Kenneth R., Howard, Emily L., Smith, R. Neal, Saylors, Robert L., Garcia, Xiomara, Jaquiss, Robert D.B., Woodle, E. Steve
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730122/
https://ncbi.nlm.nih.gov/pubmed/22179403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e31823f7eea
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы